EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Bioengineering Ovarian Endocrine Function: From Follicle Modeling to Cell‐Based Hormone Therapy

Maria João Sousa, Christiani A Amorim iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202504580 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Maria João Sousa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pôle De Recherche en Physiopathologie de La Reproduction, Instituite of Experimental and Clinique Research, Université Catholique De Louvain, Brussel…. Hauptthemen laut MEDLINE: Bioengineering, Ovarian Follicle, Hormone Replacement Therapy, Ovary. Die Arbeit nennt 169 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Foundation Louvain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Premature ovarian insufficiency (POI) is a complex endocrine disorder characterized by the loss of ovarian function before age 40, leading to infertility, hypoestrogenism, and systemic complications. Conventional hormone replacement therapies (HRTs) offer only partial relief, failing to replicate the dynamic feedback of endogenous hormone regulation. Advances in tissue engineering, stem cell technology, and microphysiological systems have catalyzed the development of bioengineered platforms that mimic native ovarian endocrine function. This review outlines progress from three‐dimensional (3D) follicle‐mimetic constructs and scaffold‐free organoids to dynamic ovary‐on‐a‐chip systems, emphasizing advances in steroidogenesis reconstitution, innovations in granulosa‐theca co‐cultures, and the design of cell‐based hormone replacement therapies (cHRTs) capable of re‐engaging the hypothalamic‐pituitary‐ovarian (HPO) axis. We also address critical translational challenges including immunoisolation, vascularization, and regulatory pathway. By bridging bioengineering and reproductive medicine, cHRTs represent a paradigm shift, offering the potential to restore endocrine health, fertility, and systemic homeostasis in a personalized and physiologically relevant manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioengineeringOvarian FollicleHormone Replacement TherapyOvaryFemaleHumansAnimalsPrimary Ovarian InsufficiencyTissue EngineeringMicrophysiological SystemsHypothalamic-Pituitary-Gonadal Axis

Stichwörter der Autor:innen

bioengineered ovarian constructshormone replacement therapyovarypremature ovary insufficiency

Autor:innen und Institutionen

  • Pôle De Recherche en Physiopathologie de La Reproduction, Instituite of Experimental and Clinique Research, Université Catholique De Louvain, Brussels, Belgium.

ORCID-Profile: Christiani A Amorim

Förderung

  • Foundation Louvain

Zitieren

APA

Sousa, M. J., & Amorim, C. A. (2026). Bioengineering Ovarian Endocrine Function: From Follicle Modeling to Cell‐Based Hormone Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504580

Vancouver

Sousa MJ, Amorim CA. Bioengineering Ovarian Endocrine Function: From Follicle Modeling to Cell‐Based Hormone Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504580

BibTeX
@article{Sousa2026,
  author = {Sousa, Maria João and Amorim, Christiani A},
  title = {Bioengineering Ovarian Endocrine Function: From Follicle Modeling to Cell‐Based Hormone Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202504580}
}
Kostenlos starten →